References
- Moe OW. Kidney stones: Pathophysiology and medical management. Lancet. 2006;367:333–344.
- Khan SR. Animal models of kidney stone formation: An analysis. World J Urol. 1997;15:236–243.
- Butterweck V, Khan SR. Herbal medicines in the management of urolithiasis: Alternative or complementary? Planta Med. 2009;75:1095–1103.
- Orhan N, Onaran M, Sen I, Isik Gonul I, Aslan M. Preventive treatment of calcium oxalate crystal deposition with immortal flowers. J Ethnopharmacol. 2015;163:60–67.
- Saha S, Verma RJ. Antinephrolithiatic and antioxidative efficacy of Dolichos biflorus seeds in a lithiasic rat model. Pharm Biol. 2015;53:16–30.
- de Cogain MR, Linnes MP, Lee HJ, et al. Aqueous extract of Costus arabicus inhibits calcium oxalate crystal growth and adhesion to renal epithelial cells. Urolithiasis. 2015;43:119–124.
- Zhang X, Wang Y, Liang Q, et al. The correlation between chemical composition, as determined by UPLC-TOF-MS, and acute toxicity of Veratrum nigrum L. and Radix paeoniae alba. Evid Based Complement Alternat Med. 2014;2014:892797.
- He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora pall., a traditional chinese herbal medicine. Front Pharmacol. 2011;2:10.
- Feng C, Liu M, Shi X, et al. Pharmacokinetic properties of paeoniflorin, albiflorin and oxypaeoniflorin after oral gavage of extracts of Radix Paeoniae Rubra and Radix Paeoniae Alba in rats. J Ethnopharmacol. 2010;130:407–413.
- Li HB, Jiang Y, Wong CC, Cheng KW, Chen F. Evaluation of two methods for the extraction of antioxidants from medicinal plants. Anal Bioanal Chem. 2007;388:483–488.
- Kulaksizoglu S, Sofikerim M, Cevik C. In vitro effect of lemon and orange juices on calcium oxalate crystallization. Int Urol Nephrol. 2008;40:589–594.
- Archer HE, Dormer AE, Scowen EF, Watts RW. Studies on the urinary excretion of oxalate by normal subjects. Clin Sci (Lond). 1957;16:405–411.
- Yamaguchi S, Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol. 2005;12:290–298.
- Li X, Liang Q, Sun Y, et al. Potential mechanisms responsible for the antinephrolithic effects of an aqueous extract of Fructus aurantii. Evid Based Complement Alternat Med. 2015;2015:491409.
- Barros M, Martinelli R, Rocha H. Experimental supratrigonal cystectomy: II-Evaluation of urinary calculi, infection, and bladder dysfunction in the pathogenesis of renal failure. Int Urol Nephrol. 2008;40:329–332.
- Nishihata M, Kohjimoto Y, Hara I. Effect of Kampo extracts on urinary stone formation: An experimental investigation. Int J Urol. 2013;20:1032–1036.
- Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int. 2005;67:1934–1943.
- Wesson JA, Ward MD. Role of crystal surface adhesion in kidney stone disease. Curr Opin Nephrol Hypertens. 2006;15:386–393.
- Khan A, Khan SR, Gilani AH. Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica. Urol Res. 2012;40:671–681.
- Sheng X, Ward MD, Wesson JA. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation. J Am Soc Nephrol. 2005;16:1904–1908.
- Xiang M, Zhang S, Lu J, et al. Antilithic effects of extracts from Urtica dentata hand on calcium oxalate urinary stones in rats. J Huazhong Univ Sci Technol Med Sci. 2011;31:673–677.
- Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study. J Urol. 1996;155:839–843.
- Menon M, Mahle CJ. Urinary citrate excretion in patients with renal calculi. J Urol. 1983;129:1158–1160.
- Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: An update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013;14:435–447.
- Goldberg H, Grass L, Vogl R, Rapoport A, Oreopoulos DG. Urine citrate and renal stone disease. CMAJ. 1989;141:217–221.
- Hugosson J, Grenabo L, Hedelin H, Lincolon K, Pettersson S. Chronic urinary tract infection and renal stones. Scand J Urol Nephrol. 1989;23:61–66.
- Holmgren K, Danielson BG, Fellstrom B, Ljunghall S, Niklasson F, Wikstrom B. The relation between urinary tract infections and stone composition in renal stone formers. Scand J Urol Nephrol. 1989;23:131–136.
- Wang X, Krambeck AE, Williams Jr JC, et al. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque. Clin J Am Soc Nephrol. 2014;9:1757–1763.
- Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, et al. Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrol Dial Transplant. 2012;27:4125–4130.
- Grover RK, Cheng J, Peng Y, et al. The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys. Proc Natl Acad Sci USA. 2012;109:6036–6041.
- Kaijser B, Hanson LA, Jodal U, Lidin-Janson G, Robbins JB. Frequency of E. coli K antigens in urinary-tract infections in children. Lancet. 1977;1:663–666.
- Chutipongtanate S, Sutthimethakorn S, Chiangjong W, Thongboonkerd V. Bacteria can promote calcium oxalate crystal growth and aggregation. J Biol Inorg Chem. 2013;18:299–308.
- Chutipongtanate S, Thongboonkerd V. Red blood cell membrane fragments but not intact red blood cells promote calcium oxalate monohydrate crystal growth and aggregation. J Urol. 2010;184:743–749.
- Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci. 2004;9:1450–1482.
- Asselman M, Verhulst A, De Broe ME, Verkoelen CF. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol. 2003;14:3155–3166.
- Alex M, Sauganth Paul MV, Abhilash M, Mathews VV, Anilkumar TV, Nair RH. Astaxanthin modulates osteopontin and transforming growth factor beta1 expression levels in a rat model of nephrolithiasis: A comparison with citrate administration. BJU Int. 2014;114:458–466.
- Katsuma S, Shiojima S, Hirasawa A, et al. Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun. 2002;296:544–552.
- Umekawa T, Iguchi M, Kurita T. The effect of osteopontin immobilized collagen granules in the seed crystal method. Urol Res. 2001;29:282–286.
- Hamamoto S, Nomura S, Yasui T, et al. Effects of impaired functional domains of osteopontin on renal crystal formation: Analyses of OPN transgenic and OPN knockout mice. J Bone Miner Res. 2010;25:2712–2723.
- Yamate T, Kohri K, Umekawa T, et al. Interaction between osteopontin on Madin Darby canine kidney cell membrane and calcium oxalate crystal. Urol Int. 1999;62:81–86.